PD-1/PD-L1-IN-33
Product Specifications
UNSPSC Description
PD-1/PD-L1-IN-33 (Compound N11) is a PD-1/PD-L1 inhibitor. PD-1/PD-L1-IN-33 inhibits PD-1 and PD-L1 interaction with an IC50: 6.3 nM. PD-1/PD-L1-IN-33 promotes T-cell proliferation, activation, and infiltration into tumor spheres. PD-1/PD-L1-IN-33 has immunomodulatory and anticancer activity[1].
Target Antigen
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-33.html
Solubility
DMSO : 100 mg/mL (ultrasonic;warming;heat to 80°C)
Smiles
CC(C)(CO)NCC1=CC2=C(N=C1)C(N3C4=C(CC3)C(C5=CC=CC=C5)=CC=C4)=NC=N2
Molecular Weight
425.53
References & Citations
[1]Yangyang Meng, et al. Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. J. Med. Chem. 2023.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155959/PD-1-PD-L1-IN-33-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155959/PD-1-PD-L1-IN-33-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2975602-78-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-28604JF669 0.1 mL
Human Monoclonal CD40/TNFRSF5 Antibody (Emory U. anti-CD40) [Janelia Fluor 669]
Ask
View Details 
